1 results match your criteria: "University-Associated City Hospital Munich-Harlaching[Affiliation]"
Nat Clin Pract Urol
April 2005
Department of Urology, University-Associated City Hospital Munich-Harlaching, Germany.
The growing interest in high-intensity focused ultrasound (HIFU) technology is mainly due to its many potential applications as a minimally invasive therapy. It has been introduced to urologic oncology as a treatment for prostate and kidney cancers. While its application in the kidney is still at the clinical feasibility phase, HIFU technology is currently used in daily practice in Europe for the treatment of prostate cancer.
View Article and Find Full Text PDF